RecruitingPhase 3NCT07067463
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
Sponsor: Zenas BioPharma (USA), LLC
Kansas City, KS · Roeland Park, KS · +17 more sites
Clinical trials in Kansas City, KS
137 recruiting studies have a site in or near Kansas City, KS, Kansas.
Top conditions here
- Parkinson's Disease (13)
- Hypertension (13)
- Heart Failure (13)
- Asthma (12)
- Lung Cancer (11)
- Prostate Cancer (11)
- Multiple Sclerosis (11)
- Breast Cancer (10)
All conditions
- Alzheimer's Disease
- Asthma
- Breast Cancer
- COPD
- Crohn's Disease
- Depression
- Type 1 Diabetes
- Type 2 Diabetes
- Heart Failure
- Hypertension
- Leukemia
- Lung Cancer
- Lupus
- Migraine
- Multiple Sclerosis
- Obesity
- Parkinson's Disease
- Prostate Cancer
- Psoriasis
- Rheumatoid Arthritis
- Schizophrenia
- Sickle Cell Disease
- Ulcerative Colitis
- Colorectal Cancer
Showing 40 of 137 studies
RecruitingPhase 3NCT03150693
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
Sponsor: Alliance for Clinical Trials in Oncology
Garden City, KS · Great Bend, KS · Kansas City, KS · +452 more sites
RecruitingPhase 3NCT04267848
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Sponsor: National Cancer Institute (NCI)
Chanute, KS · Dodge City, KS · El Dorado, KS · +1147 more sites
RecruitingNot applicableNCT06891755
Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
Sponsor: Apreo Health, Inc.
Kansas City, KS · +17 more sites
RecruitingPhase 3NCT07190209
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
Sponsor: Sanofi
Kansas City, KS · +74 more sites
RecruitingPhase 2NCT05554393
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Sponsor: National Cancer Institute (NCI)
Fairway, KS · Kansas City, KS · Overland Park, KS · +172 more sites
RecruitingPhase 3NCT07391774
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial
Sponsor: National Cancer Institute (NCI)
Kansas City, KS · Olathe, KS · Overland Park, KS · +200 more sites
RecruitingPhase 1NCT03460977
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
Sponsor: Pfizer
Fairway, KS · Kansas City, KS · +42 more sites
RecruitingPhase 3NCT06617325
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
Sponsor: UCB Biopharma SRL
Kansas City, KS · +62 more sites
RecruitingPhase 2NCT06958536
A Study to Investigate Efficacy and Safety of Brivekimig in Participants With Crohn's Disease
Sponsor: Sanofi
Kansas City, KS · +19 more sites
RecruitingPhase 3NCT07181109
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Sponsor: Alnylam Pharmaceuticals
Hutchinson, KS · Kansas City, KS · Topeka, KS · +270 more sites
RecruitingPhase 2NCT06317649
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Sponsor: National Cancer Institute (NCI)
Fairway, KS · Kansas City, KS · Overland Park, KS · +222 more sites
RecruitingPhase 3NCT06935370
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Sponsor: Boehringer Ingelheim
Kansas City, KS · Wichita, KS · +86 more sites
RecruitingPhase 3NCT06307665
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
Sponsor: AstraZeneca
Kansas City, KS · +119 more sites
RecruitingPhase 3NCT06430801
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Sponsor: Merck Sharp & Dohme LLC
Kansas City, KS · Topeka, KS · +85 more sites
RecruitingPhase 2NCT06434571
Comparing Telehealth-Delivered CBT-I to Web-Based CBT-I to Enhance Sleep, Reduce Fatigue, and Promote Neuroprotection
Sponsor: University of Kansas Medical Center
Kansas City, KS
RecruitingPhase 4NCT06478186
Knee Osteoarthritis Treatment With Zilretta vs. Kenalog in the Context of Type II Diabetes
Sponsor: University of Kansas Medical Center
Kansas City, KS
RecruitingPhase 2NCT06672146
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Sponsor: National Cancer Institute (NCI)
Fairway, KS · Kansas City, KS · Westwood, KS · +132 more sites
RecruitingPhase 3NCT06736574
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Sponsor: Cytokinetics
Kansas City, KS · Overland Park, KS · +86 more sites
RecruitingNot applicableNCT06898515
Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)
Sponsor: Reprieve Cardiovascular, Inc
Kansas City, KS · +34 more sites
RecruitingPhase 2NCT06977581
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
Sponsor: Pfizer
Kansas City, KS · +35 more sites
RecruitingPhase 3NCT07179380
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Sponsor: Insmed Incorporated
Kansas City, KS · +18 more sites
RecruitingPhase 3NCT07225504
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
Sponsor: Novartis Pharmaceuticals
Kansas City, KS · +42 more sites
RecruitingPhase not listedNCT07428447
Analysis of Cutaneous Phosphorylated Alpha-Synuclein to Identify Patients at Risk of Progressing From Essential Tremor to Parkinson's Disease
Sponsor: CND Life Sciences
Kansas City, KS · +7 more sites
RecruitingPhase 2NCT06031688
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Sponsor: SWOG Cancer Research Network
Fairway, KS · Hays, KS · Kansas City, KS · +275 more sites
RecruitingPhase 3NCT06878261
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
Sponsor: AstraZeneca
Kansas City, KS · +79 more sites
RecruitingPhase 3NCT03678025
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Sponsor: SWOG Cancer Research Network
Kansas City, KS · Olathe, KS · Overland Park, KS · +331 more sites
RecruitingPhase 2NCT07175038
A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
Sponsor: AllRock Bio, Inc.
Kansas City, KS · +10 more sites
RecruitingPhase 2NCT07745361
Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
Sponsor: Monte Rosa Therapeutics, Inc
Kansas City, KS · +13 more sites
RecruitingPhase 1 / Phase 2NCT06710756
Lead-212 PSV359 Therapy for Patients With Solid Tumors
Sponsor: Perspective Therapeutics
Kansas City, KS · +15 more sites
RecruitingPhase not listedNCT07143669
Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations
Sponsor: Blueprint Medicines Corporation
Kansas City, KS · +24 more sites
RecruitingPhase 3NCT07359846
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)
Sponsor: Generate Biomedicines
Kansas City, KS · +20 more sites
RecruitingPhase 1 / Phase 2NCT06121297
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
Sponsor: Cabaletta Bio
Kansas City, KS · +20 more sites
RecruitingPhase 2NCT07012395
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Sponsor: Spyre Therapeutics, Inc.
Kansas City, KS · +25 more sites
RecruitingPhase 3NCT07174310
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
Sponsor: Hoffmann-La Roche
Kansas City, KS · +52 more sites
RecruitingPhase 2NCT07323654
A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma
Sponsor: Kymera Therapeutics, Inc.
Kansas City, KS · +33 more sites
RecruitingPhase 2NCT07432958
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
Sponsor: Appello Pharmaceuticals, Inc.
Kansas City, KS · +29 more sites
RecruitingPhase 1NCT03816345
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Sponsor: National Cancer Institute (NCI)
Fairway, KS · Hays, KS · Kansas City, KS · +48 more sites
RecruitingPhase 2NCT06707493
Ivosidenib as Post-HSCT Maintenance for AML
Sponsor: Massachusetts General Hospital
Kansas City, KS · +6 more sites
RecruitingNot applicableNCT03523416
Early Feasibility Study - Edwards APTURE Transcatheter Shunt System
Sponsor: Edwards Lifesciences
Kansas City, KS · +18 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.